Bello L - Search Results

1

Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system.

Miraux S, Lemière S, Pineau R, Pluderi M, Canioni P, Franconi JM, Thiaudière E, Bello L, Bikfalvi A, Auguste P. Miraux S, et al. Among authors: bello l. Angiogenesis. 2004;7(2):105-13. doi: 10.1007/s10456-004-1037-0. Angiogenesis. 2004. PMID: 15516831

2

Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A. Hagedorn M, et al. Among authors: bello l. Cancer Res. 2002 Dec 1;62(23):6884-90. Cancer Res. 2002. PMID: 12460903

3

IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.

Bello L, Lucini V, Giussani C, Carrabba G, Pluderi M, Scaglione F, Tomei G, Villani R, Black PM, Bikfalvi A, Carroll RS. Bello L, et al. Neurosurgery. 2003 Jan;52(1):177-85; discussion 185-6. doi: 10.1097/00006123-200301000-00023. Neurosurgery. 2003. PMID: 12493116

4

Angiogenesis and invasion in gliomas.

Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A. Bello L, et al. Cancer Treat Res. 2004;117:263-84. doi: 10.1007/978-1-4419-8871-3_16. Cancer Treat Res. 2004. PMID: 15015565 Review.

5

Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma.

Bello L, Lucini V, Costa F, Pluderi M, Giussani C, Acerbi F, Carrabba G, Pannacci M, Caronzolo D, Grosso S, Shinkaruk S, Colleoni F, Canron X, Tomei G, Deleris G, Bikfalvi A. Bello L, et al. Clin Cancer Res. 2004 Jul 1;10(13):4527-37. doi: 10.1158/1078-0432.CCR-04-0194. Clin Cancer Res. 2004. PMID: 15240545

6

Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.

Bello L, Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Tomei G, Villani R, Scaglione F, Carroll RS, Bikfalvi A. Bello L, et al. Clin Cancer Res. 2002 Nov;8(11):3539-48. Clin Cancer Res. 2002. PMID: 12429645

7

Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A. Zilberberg L, et al. Among authors: bello l. J Biol Chem. 2003 Sep 12;278(37):35564-73. doi: 10.1074/jbc.M304435200. Epub 2003 Jul 1. J Biol Chem. 2003. PMID: 12837752 Free article.

8

Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.

Saidi A, Hagedorn M, Allain N, Verpelli C, Sala C, Bello L, Bikfalvi A, Javerzat S. Saidi A, et al. Among authors: bello l. Int J Cancer. 2009 Sep 1;125(5):1054-64. doi: 10.1002/ijc.24380. Int J Cancer. 2009. PMID: 19431143 Free article.

9

Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.

Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM. Bello L, et al. Cancer Res. 2001 Dec 15;61(24):8730-6. Cancer Res. 2001. PMID: 11751392

10

Long-term inhibition of glioma growth by systemic administration of human PEX.

Pluderi M, Lucini V, Caronzolo D, Pannacci M, Costa F, Carrabba G, Giussani C, Grosso S, Colleoni F, Scaglione F, Villani R, Bikfalvi A, Bello L. Pluderi M, et al. Among authors: bello l. J Neurosurg Sci. 2003 Jun;47(2):69-78. J Neurosurg Sci. 2003. PMID: 14618134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page